SIRT1, a class III histone deacetylase, regulates TNF-α-induced inflammation in human chondrocytes

Osteoarthritis and Cartilage

Volumn 21, Issue 3, 2013, Pages 470-480

  Moon, M H ^a   Jeong, J K ^a   Lee, Y J ^a   Seol, J W ^a   Jackson, C J ^b   Park, S Y ^a  

^a Chonbuk National University   (South Korea)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Chondrocytes; COX 2; Inflammation; SIRT1

Indexed keywords

COLLAGENASE 3; CYCLOOXYGENASE 2; GELATIN; GELATINASE A; GELATINASE B; GLYCOSAMINOGLYCAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERSTITIAL COLLAGENASE; PROSTAGLANDIN E2; RESVERATROL; SIRTINOL; SIRTUIN 1; STROMELYSIN; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; CARTILAGE CELL; CARTILAGE DEGENERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOTTING, WESTERN; CARTILAGE, ARTICULAR; CHONDROCYTES; CYCLOOXYGENASE 2; DINOPROSTONE; HUMANS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; NF-KAPPA B; OSTEOARTHRITIS, KNEE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIRTUIN 1; STILBENES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84873151285     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2012.11.017     Document Type: Article

References (40)

1. 2 production in human chondrocytes. Osteoarthritis Cartilage 2008, 16:1267-1274.
2. Goldring M.B., Marcu K.B. Cartilage homeostasis in health and rheumatic diseases. Arthritis Res Ther 2009, 11:224.
3. Goldring M.B., Berenbaum F. Human chondrocyte culture models for studying cyclooxygenase expression and prostaglandin regulation of collagen gene expression. Osteoarthritis Cartilage 1999, 7:386-388.
4. Kim H.A., Yeo Y., Kim W.U., Kim S. Phase 2 enzyme inducer sulphoraphane blocks matrix metalloproteinase production in articular chondrocytes. Rheumatology (Oxford) 2009, 48:932-938.
5. Lianxu C., Hongti J., Changlong Y. NF-[kappa]Bp65-specific siRNA inhibits expression of genes of COX-2, NOS-2 and MMP-9 in rat IL-1[beta]-induced and TNF-[alpha]-induced chondrocytes. Osteoarthritis Cartilage 2006, 14:367-376.
6. Pelletier J.P., Martel-Pelletier J., Abramson S.B. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum 2001, 44:1237-1247.
7. Kopp E.B., Ghosh S. NF-kappa B and Rel proteins in innate immunity. Adv Immunol 1995, 58:1-27.
8. Newton R., Kuitert L.M., Bergmann M., Adcock I.M., Barnes P.J. Evidence for involvement of NF-kappaB in the transcriptional control of COX-2 gene expression by IL-1beta. Biochem Biophys Res Commun 1997, 237:28-32.
9. Bordone L., Guarente L. Calorie restriction, SIRT1 and metabolism: understanding longevity. Nat Rev Mol Cell Biol 2005, 6:298-305.
10. Cohen H.Y., Miller C., Bitterman K.J., Wall N.R., Hekking B., Kessler B., et al. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 2004, 305:390-392.
11. Guarente L., Picard F. Calorie restriction - the SIR2 connection. Cell 2005, 120:473-482.
12. Seo J.S., Moon M.H., Jeong J.K., Seol J.W., Lee Y.J., Park B.H., et al. SIRT1, a histone deacetylase, regulates prion protein-induced neuronal cell death. Neurobiol Aging 2012, 336:1110-1120.
13. Dvir-Ginzberg M., Gagarina V., Lee E.J., Hall D.J. Regulation of cartilage-specific gene expression in human chondrocytes by SirT1 and nicotinamide phosphoribosyltransferase. J Biol Chem 2008, 283:36300-36310.
14. Gagarina V., Gabay O., Dvir-Ginzberg M., Lee E.J., Brady J.K., Quon M.J., et al. SirT1 enhances survival of human osteoarthritic chondrocytes by repressing protein tyrosine phosphatase 1B and activating the insulin-like growth factor receptor pathway. Arthritis Rheum 2010, 62:1383-1392.
15. Dave M., Attur M., Palmer G., Al-Mussawir H.E., Kennish L., Patel J., et al. The antioxidant resveratrol protects against chondrocyte apoptosis via effects on mitochondrial polarization and ATP production. Arthritis Rheum 2008, 58:2786-2797.
16. Csaki C., Keshishzadeh N., Fischer K., Shakibaei M. Regulation of inflammation signalling by resveratrol in human chondrocytes in vitro. Biochem Pharmacol 2008, 75:677-687.
17. Yang S.R., Wright J., Bauter M., Seweryniak K., Kode A., Rahman I. Sirtuin regulates cigarette smoke-induced proinflammatory mediator release via RelA/p65 NF-kappaB in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging. Am J Physiol Lung Cell Mol Physiol 2007, 292:L567-L576.
18. Seol J., Lee H., Lee Y., Lee Y., Kang H., Kim I., et al. Hypoxic resistance to articular chondrocyte apoptosis - a possible mechanism of maintaining homeostasis of normal articular cartilage. FEBS Journal 2009, 276:7375-7385.
19. Stannus O., Jones G., Cicuttini F., Parameswaran V., Quinn S., Burgess J., et al. Circulating levels of IL-6 and TNF-alpha are associated with knee radiographic osteoarthritis and knee cartilage loss in older adults. Osteoarthritis Cartilage 2010, 18:1441-1447.
20. Hedbom E., Häuselmann H. Molecular aspects of pathogenesis in osteoarthritis: the role of inflammation. Cell Mol Life Sci 2002, 59:45-53.
21. Fernandes J.C., Martel-Pelletier J., Pelletier J.P. The role of cytokines in osteoarthritis pathophysiology. Biorheology 2002, 39:237-246.
22. Smith M., Triantafillou S., Parker A., Youssef P., Coleman M. Synovial membrane inflammation and cytokine production in patients with early osteoarthritis. J Rheumatol 1997, 24:365.
23. Goldring M.B. The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models. Connect Tissue Res 1999, 40:1-11.
24. Zhang R., Chen H.Z., Liu J.J., Jia Y.Y., Zhang Z.Q., Yang R.F., et al. SIRT1 suppresses activator protein-1 transcriptional activity and cyclooxygenase-2 expression in macrophages. J Biol Chem 2010, 285:7097-7110.
25. Burrage P.S., Mix K.S., Brinckerhoff C.E. Matrix metalloproteinases: role in arthritis. Front Biosci 2006, 11:529-543.
26. Martel-Pelletier J., Welsch D.J., Pelletier J.P. Metalloproteinases and inhibitors in arthritic diseases. Best Pract Res Clin Rheumatol 2001, 15:805-829.
27. Thomas C.M., Fuller C.J., Whittles C.E., Sharif M. Chondrocyte death by apoptosis is associated with cartilage matrix degradation. Osteoarthritis Cartilage 2007, 15:27-34.
28. Chung S., Yao H., Caito S., Hwang J.-w., Arunachalam G., Rahman I. Regulation of SIRT1 in cellular functions: role of polyphenols. Arch Biochem Biophys 2010, 501:79-90.
29. Shakibaei M., Csaki C., Nebrich S., Mobasheri A. Resveratrol suppresses interleukin-1beta-induced inflammatory signaling and apoptosis in human articular chondrocytes: potential for use as a novel nutraceutical for the treatment of osteoarthritis. Biochem Pharmacol 2008, 76:1426-1439.
30. Shakibaei M., John T., Schulze-Tanzil G., Lehmann I., Mobasheri A. Suppression of NF-[kappa]B activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis. Biochem Pharmacol 2007, 73:1434-1445.
31. Takayama K., Ishida K., Matsushita T., Fujita N., Hayashi S., Sasaki K., et al. SIRT1 regulation of apoptosis of human chondrocytes. Arthritis Rheum 2009, 60:2731-2740.
32. Kaeberlein M., McDonagh T., Heltweg B., Hixon J., Westman E.A., Caldwell S.D., et al. Substrate-specific activation of sirtuins by resveratrol. J Biol Chem 2005, 280:17038-17045.
33. Baur J.A., Pearson K.J., Price N.L., Jamieson H.A., Lerin C., Kalra A., et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006, 444:337-342.
34. Dvir-Ginzberg M., Gagarina V., Lee E.J., Booth R., Gabay O., Hall D.J. Tumor necrosis factor alpha-mediated cleavage and inactivation of SirT1 in human osteoarthritic chondrocytes. Arthritis Rheum 2011, 63:2363-2373.
35. Csaki C., Mobasheri A., Shakibaei M. Synergistic chondroprotective effects of curcumin and resveratrol in human articular chondrocytes: inhibition of IL-1beta-induced NF-kappaB-mediated inflammation and apoptosis. Arthritis Res Ther 2009, 11:R165.
36. Milner J.M., Cawston T.E. Matrix metalloproteinase knockout studies and the potential use of matrix metalloproteinase inhibitors in the rheumatic diseases. Curr Drug Targets Inflamm Allergy 2005, 4:363-375.
37. Burrage P.S., Huntington J.T., Sporn M.B., Brinckerhoff C.E. Regulation of matrix metalloproteinase gene expression by a retinoid X receptor-specific ligand. Arthritis Rheum 2007, 56:892-904.
38. Chen L.F., Mu Y., Greene W.C. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. EMBO J 2002, 21:6539-6548.
39. Mayo M.W., Denlinger C.E., Broad R.M., Yeung F., Reilly E.T., Shi Y., et al. Ineffectiveness of histone deacetylase inhibitors to induce apoptosis involves the transcriptional activation of NF-kappa B through the Akt pathway. J Biol Chem 2003, 278:18980-18989.
40. Ashburner B.P., Westerheide S.D., Baldwin A.S. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol 2001, 21:7065-7077.